Description: Sanofi-Aventis SA, Franceâ€™s largest drugmaker, got about $10 billion of underwritten loans to back its bid for U.S. biotechnology company Genzyme Corp., two people familiar with the situation said .
Questions for discussion:
- What does this report have to say about the financial state of some European banks and the firms they are financing?
- Do you think this report suggests that creditÂ might not be as much of as problem as it has been since the crisis?
- How should other banks, borrowers, and investors respond to this report?
- What does this report suggest about current stock market valuations?